`ESTTA669355
`ESTTA Tracking number:
`04/29/2015
`
`Filing date:
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`Notice of Opposition
`
`Notice is hereby given that the following party opposes registration of the indicated application.
`Opposer Information
`
`Name
`Entity
`Address
`
`Bayer HealthCare LLC
`Limited Liability Company
`100 Bayer Road
`Pittsburgh, PA 15205
`UNITED STATES
`
`Citizenship
`
`Delaware
`
`Attorney informa-
`tion
`
`Richard J. Groos
`Norton Rose Fulbright US LLP
`98 San Jacinto Blvd., Suite 1100
`Austin, TX 78701
`UNITED STATES
`aoipdocket@nortonrosefulbright.com, brandon.ress@nortonrosefulbright.com,
`erin.molson@nortonrosefulbright.com Phone:512.474.5201
`Applicant Information
`
`86476019
`04/29/2015
`
`Application No
`Opposition Filing
`Date
`Applicant
`
`Publication date
`Opposition Peri-
`od Ends
`Jiangsu Lefan Capsule Co.,Ltd.
`No. 71 Hengyuan Road, Dantu New Town
`Jiangsu Province,
`CHINA
`Goods/Services Affected by Opposition
`
`03/31/2015
`04/30/2015
`
`Class 005. First Use: 2013/10/18 First Use In Commerce: 2013/10/18
`All goods and services in the class are opposed, namely: Capsules sold empty for pharmaceuticals;
`Gelatin capsules sold empty for pharmaceuticals; Nutritional supplements in the form of capsules and
`caplets; Unit dose capsules sold empty for pharmaceuticaluse
`
`Grounds for Opposition
`
`Priority and likelihood of confusion
`Dilution
`
`Trademark Act section 2(d)
`Trademark Act section 43(c)
`
`Marks Cited by Opposer as Basis for Opposition
`
`U.S. Registration
`No.
`Registration Date
`
`1536042
`
`04/25/1989
`
`Word Mark
`Design Mark
`
`ALEVE
`
`Application Date
`
`05/05/1988
`
`Foreign Priority
`Date
`
`NONE
`
`
`
`Description of
`Mark
`Goods/Services
`
`NONE
`
`Class 005. First use: First Use: 1988/04/25 First Use In Commerce: 1988/04/25
`ANTI-INFLAMMATORY, ANALGESIC, AND ANTIPYRETIC PHARMACEUTIC-
`AL PREPARATIONS
`
`U.S. Registration
`No.
`Registration Date
`
`3287780
`
`09/04/2007
`
`Word Mark
`Design Mark
`
`ALEVE
`
`Application Date
`
`02/13/2007
`
`Foreign Priority
`Date
`
`NONE
`
`Description of
`Mark
`Goods/Services
`
`NONE
`
`Class 005. First use: First Use: 2000/07/31 First Use In Commerce: 2000/07/31
`Pharmaceutical antitussive-cold preparations; Preparations for treating colds
`
`Attachments
`
`77105868#TMSN.png( bytes )
`86476019.pdf(2193963 bytes )
`
`The undersigned hereby certifies that a copy of this paper has been served upon all parties, at their address
`record by First Class Mail on this date.
`
`Certificate of Service
`
`Signature
`Name
`Date
`
`/Brandon M. Ress/
`Brandon M. Ress
`04/29/2015
`
`
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`In the matter of Application Serial No. 86/476,019
`By Jiangsu Lefan Capsule C0,, Ltd. for the Mark: LEVECAPS IT’S SAFE AND STABLE
`Filed on December 10, 2014, Published in the Oflicial Gazette on March 31, 2015
`
`BAYER HEALTHCARE LLC,
`
`Opposer,
`
`V-
`
`Opposition No.
`
`JIANGSU LEFAN CAPSULE CO., LTD.,
`
`Applicant.
`
`NOTICE OF OPPOSITION
`
`Bayer HealthCare LLC (“Opposer”), a Delaware limited liability company having a
`
`principal place of business at 100 Bayer Road, Pittsburgh, Pennsylvania 15205, believes that it
`
`will be damaged by registration of the mark “LEVECAPS IT’S SAFE AND STABLE” as shown
`
`in Application Serial No. 86/476,019 for goods in International Class 5 (the “Application”) and
`
`hereby opposes the same.
`
`As the grounds of Opposition, Opposer alleges that:
`
`1.
`
`Jiangsu Lefan Capsule Co., Ltd. (“Applicant”) filed a use-based application to
`
`register the mark “LEVECAPS IT’S SAFE AND STABLE” for “Capsules sold empty for
`
`pharmaceuticals; Gelatin capsules sold empty for pharmaceuticals; Nutritional supplements in
`
`the form of capsules and caplets; Unite dose capsules sold empty for pharmaceutical use” in
`
`International Class 5 as evidenced by the publication of such mark in the Official Gazette on
`
`March 31,2015.
`
`58475305.]
`
`
`
`2.
`
`Through its predecessors-in-interest, Opposer has, since at least as early as April
`
`25, 1988, used the mark ALEVE in connection with products related to the treatment of pain,
`
`and in connection with preparations for treating colds since as early as 2000. Opposer is the
`
`owner of, among others, an incontestable registration for the trademark “ALEVE” (United States
`
`Registration No. 1,536,042, registered April 25, 1989) for “anti-inflammatory, analgesic and
`
`antipyretic pharmaceutical preparations” in Class 5 and a registration for the trademark
`
`“ALEVE” (United States Registration No. 3,287,780,
`
`registered September 4, 2007)
`
`for
`
`“pharmaceutical antitussive—cold preparations; preparations for treating colds” in Class 5.
`
`Printouts of the TSDR database information for these registrations are attached as Exhibit A.
`
`3.
`
`By virtue of its promotional and advertising activities and the excellence of its
`
`goods, Opposer has gained for its mark “ALEVE” a most valuable reputation and has created, in
`
`the minds of the buying public, an exclusive association between “ALEVE” and its goods.
`
`4.
`
`Applicant’s alleged mark is confilsingly similar to Opposer’s ALEVE mark in
`
`appearance, sound, connotation, and commercial
`
`impression. Upon information and belief,
`
`Applicant’s proposed mark is intended to be used for goods which are identical, similar and/or
`
`related to the goods in connection with which Opposer has used its “ALEVE” mark and are sold
`
`to substantially the same class of customers through the same charmels of trade.
`
`5.
`
`Priority is not an issue. Opposer has used the “ALEVE” mark prior to the
`
`Applicant’s application date of October 24, 2013, and prior to the claimed first use date of
`
`October 18, 2013, contained in the opposed application.
`
`6.
`
`Opposer filed its applications for “ALEVE” prior to the filing date and claimed
`
`first use date of the opposed application.
`
`58475305.]
`
`2
`
`
`
`7.
`
`Use by Applicant of the alleged trademark “LEVECAPS IT’S SAFE AND
`
`STABLE” is without Opposer's consent or permission.
`
`8.
`
`Opposer filed a Notice of Opposition against Applicant’s prior application, Serial
`
`No. 86/099,953 to register the trademark “LEVECAPS.” Applicant defaulted in that proceeding
`
`and the opposition was sustained.
`
`9.
`
`LEVECAPS is the dominant portion of Applicant’s alleged trademark, as
`
`evidenced both by the stylization of the trademark, and Applicant’s prior use-based application
`
`to register “LEVECAPS.”
`
`10.
`
`The mark that Applicant seeks to register so resembles Opposer’s “ALEVE” mark
`
`as to be likely, when used on or in connection with Applicant’s goods, to cause confusion, or to
`
`cause mistake, or to deceive. Purchasers and prospective purchasers are likely to falsely believe
`
`that Applicant’s goods offered under Applicant’s Mark are sponsored, endorsed, or approved by
`
`Opposer, or are in some way affiliated, connected or associated with Opposer. Furthermore, any
`
`defect, objection or fault found with Applicant’s goods offered and sold under its “LEVECAPS
`
`IT’S SAFE AND STABLE” mark would be likely to reflect upon and seriously injure the
`
`reputation that Opposer has established for its goods offered under its “ALEVE” mark.
`
`Registration therefore should be refused under 15 U.S.C. § lOS2(d).
`
`11.
`
`The mark “ALEVE” is distinctive and famous throughout the United States, and
`
`has become closely associated with the goods of Opposer. The “ALEVE” mark became famous
`
`prior to the filing of Applicant’s application for “LEVECAPS IT’S SAFE AND STABLE.”
`
`12.
`
`The trademark proposed for registration by Applicant, namely, “LEVECAPS IT’S
`
`SAFE AND STABLE,” is likely to cause dilution by blurring and dilution by tamishment of
`
`53475305.:
`
`3
`
`
`
`Opposer’s “ALEVE” mark, and also reduces the capacity of the famous “ALEVE” mark to
`
`identify the goods of Opposer.
`
`13.
`
`If Applicant is granted the registration herein opposed, it would thereby obtain at
`
`least a prima facie exclusive right to the use of its alleged mark. Such registration would be a
`
`source of damage and injury to Opposer.
`
`WHEREFORE, Bayer HealthCare LLC prays that Application Serial No. 86/476,019 be
`
`rejected, and that registration of the mark therein be refused and that the opposition be sustained.
`
`I ' we"- Dated: April 29, 2015
`
`Respectfully
`
`By:
`
`NORTON ROSE FULBRIGHT US LLP
`
`98 San Jacinto Blvd., Suite 1100
`
`Austin, Texas 78701
`Tel: 512.474.5201
`
`Fax: 512.536.4598
`
`ATTORNEYS FOR OPPOSER
`
`58475305.]
`
`4
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that a true and correct copy of the NOTICE OF OPPOSITION has been served
`via Certified Mail Return Receipt Requested to AppIicant’s correspondence address of record on
`this the 29”" day of April 2015:
`
`Tony Tune
`1068SB I-Iazelhurst Dr. #6254
`
`Houston, Texas 77043-3238
`
`534753051
`
`5
`
`
`
`EXHIBIT A
`
`
`
`United States Patent and Trademark Office
`An Aguiicy nftlic DL'[JJl‘ll1\L‘l1l ll].(‘.nl1]|11CI'CI.‘
`
`Trademark Status and Document Retrieval
`
`xpiaunpoiiq paudumas-wk-s
`1.-_i-ii-mi-L,
`'Abau:usI;-to mini;
`USPTU > ‘rradeniark -.- TSDR > Trademark Search
`
`(‘J1-I-er:
`
`In-.-anmn New-glfimleou
`
`nnusisuesslnlens
`
`FAQ: Fnrlfida
`
`“—\\ Tmcleniark Status Si lmciiiiieiit Retrieval (TSDR) 0
`
`SEARCH
`
`i.v.:i.ri.su.:cii O
`.—"i
`.‘l
`
`E\DCLlI.1EllT5 0
`Generated on: Time L‘3;,'E".1rBé generate-.1 2, GDP: an J01E—0~ .3-:4 13,1‘. 37 EDT
`Mark:
`I-LE‘.-E
`
`H-3 lrriar;-2‘ ‘.-1131': TEE "M3 E33‘.-
`
`Application Filing Date: H3‘
`
`:‘
`
`R&<J|-'=lf«3“f"| 0315-2
`
`‘fir fir"
`
`US Senalllunibs-r“.
`
`.
`
`-
`
`-
`
`:
`
`’
`
`us Registration Number:
`7
`Register.
`f.1i1skType: Trad-Emal-1'
`Status:
`tn-3 f‘.*Qi£lI31‘i-3i’1 nae ::-sen len-
`Status Dale:
`Publication Date:
`v Mark Information
`Mark Literal Elements:
`Standard Characterciaim: Hr.-
`
`HdI|vl(3fd.‘u'i‘i1'lflT)'|)uZ 1 -T‘«'PESET'.".'ORE.‘i'5E r‘i.ETTERi‘3: Tl'Jl'.|BERlS?
`v Goods and Services
`' Hail
`
`’ =
`
`.
`
`lnlerrialionalclasslesl:
`Class Status: 2
`Basis:
`FK51 Use:
`
`- Basis lnloriiintion (Case Level}
`fill;-d Use:
`res
`Film! ITU:
`lln
`Filed -141):
`E
`-
`filed ME:
`=.
`Filed 66¢:
`'
`Filr.-i1 llu Basis:
`llo
`
`r Current 0wrier[s| Information
`Owner llama‘. E:-‘-'i'E!'\‘ HEALTHCRRE LLC
`Ownemdrsrass:
`1-30 BAYER RU!-D
`PIITSEURGH PEtJ!l‘3‘n‘LV-'-l-ll—'
`UNITED STATES
`
`Legal Entity Type:
`
`I_::.ii'l‘ED !_IaEeLITT CCiI.:=-:.r:\
`
`v Attorneylcorrespnndence lnforniation
`Artcrnay orRe-zord
`l.l Gitcti-‘A
`J-:—"i:e.
`Mlurnegtlame:
`Attorney Primary Emall EZl_,EfTfE3?-“'13!-‘U'E@:3
`Address:
`
`'-:-r i::vii
`
`Correspondent
`I'_‘-ltcriei
`Coin:-spotiuenl Jellre. i.i
`tlarnclilddriyss:
`'::iier Cnraaramn
`IL?-3 Ea~=-i R036
`ran FEll:-IS‘rL‘-.-min 15205
`_i'.i ST—‘.TES
`
`U.5Classles:: 013
`
`Usemliurnnwrce:
`
`-‘er 2:‘ was
`
`Curriznily Use:
`Cllh‘EnllyiTU:
`Currently -143:
`Currently-44E:
`Currently 65A:
`Currerillyllo Bi!5l52 flu:
`
`‘
`-2:
`-.
`
`Amended Use:
`amended lTU:
`Amended -MD:
`Amended -ME:
`
`stale or Cuuritry Where» E,-El,A.‘.‘.-ARE
`Orqanrred‘.
`
`UOCRBINUHILWEF.
`Asiomey Email nuinonzeu:
`
`1
`‘.‘
`
`Fail:
`
`-112-??3—:-€32
`
`
`
`correspondent e.marI: E-'3 . -?rTI.'r.: -«-
`
`
`Carrestwndenl E-mall
`Aumonzea:
`
`'- PE-
`
`Domestic Representative - Not Found
`v Prosecution History
`Dale
`Jul 1'1 2U-.19
`
`Jul. .21, 2903
`
`‘Cr 22 2039
`.=.1r 20 2099
`Rug 19.2038
`Jan 10 2007
`
`5;; 5: 3:333
`:;r 2321332
`Jul 14‘ 5031
`Jan 15. 2301
`C11 05 20317
`l.lar \1E_1§98
`
`15:95‘
`Del: 11
`Liar 23.1995
`-'«.:r 25. 1389
`J.1n.31,1*3B9
`J-JG El? 19833
`De: 21_19EB
`Cd 21 I933
`Sep 05,1935
`Jul 17,1933
`Jul 93, 1933
`Jul M1 193%
`
`Description
`REWSTERED LIID RENEWED LFIRST F\‘EHE‘-‘- 3-L’
`10 YRS‘:
`REG€STERED - SEC‘ 8 i1£=-YR),-\CCEF’lE[.‘;.~'SEC ‘J
`GRFIITED
`EG=l.
`-’~.:E:SHED TO r"—'F-‘.
`T -‘-S EEC‘l'lCli El 6. 9 RECEHED
`CAGE FILEllJ'.'lCR‘3
`IEVUTCIJATEC UPDAYE OF 4.55-lGH|.lEll'|’ OF
`
`G‘.
` . REHlP
`
`
`
`- SEC, 3
`
`:cun7ERC:.~'ll.1 CPP l‘l'3 G9-99-:-3
`TE-‘-S CHSHGE [IF CCRRESPMIDEIICE Fs'ECEl‘a’EC-
`R['_n3lSTEREtI - SEC 15 ‘Ii-.HH3‘.'-‘LED3E[‘J
`
`REIESTERED - SEC 1
`FFlD;‘-‘.'i7 FLED
`P:'_l3T RE-.'_‘.ISTR=.I:,‘.l'l 4573?.‘ -C-CFEHECTIJII
`REQSTERED - SEC 81.5-‘i'R‘n‘«CCEF'TED 5- SEC 15
`HCK
`PCS? FEGIE TR-‘~TlC!H LCYEOIJ l.1-‘-JLEC:
`REGESTERED - SEC 5 rvSA1'R; FILED
`
`REGES EF-!EC‘rFRIl'J'.'.1P-'-L REGPETEE
`FUEiLlSHEC| FUR \'.|PFDSlTl'LlH
`TICTJCE C.‘-F FUISLICA‘-‘ll3N
`|lCTiCE Cr’ 1'-lJI3L|Cv=Tl3H
`IETER
`.-PFRO-IED FUR FLT; - F-'?ll'JClF‘-‘~L R‘
`
`CORRESPOIJDEHCE RECEP-JED:r1LA‘-‘JSFFICE
`llOH-Fl=‘.liL -'-CT.C‘-Hl.1i-iLEE‘-
`=S3lG!3ED TC E:(;:llIHEa
`-'<S'.3l‘C‘:|iED TO E‘.-HIIJER
`
`Proceeding Ilumber
`?'-7133
`
`TCH32
`
`1;‘-viala
`
`52:3?1
`E-5‘-3E-'
`
`Date In Locauon: Jui 21, 2-.709
`
`' Cr;m.u:-y:m:.e Film:
`Rewslranl: SHHTE-. FLJERTC RlCC‘ HJC
`
`
`
`Pages:
`
`3
`
`Execauon Dare: Cd 12. 1"."-.‘1
`
`Slate or Country Where I50 Place '.'.'ln'.-H.- Crlzamz-:1.‘ Found
`Organized:
`
`Slate or Country Whc,\ri,> E.EL-'-L‘;-‘-l’-'<E
`Drganued:
`
`v Maintenance Filings or Post Registration information
`.F\I‘fidfl\'l1G§C0nllnU&d Use: Se-Ill:-H 3 ~ Lc
`
`Amaa-rn or Inconresrabiirry:
`.—.-.-
`.-'L-: 25. 2009
`Renewnl Dale:
`
`- Tl-ll Staff and Location Information
`TM slafilnlunnauon - None
`file Location
`Current Location: POST F-IEGISFR-\T|’Jl|
`
`v Assignmentikhstract Of ‘|"It|e Information
`summary
`Tolai Assaqnnxenrs:
`
`9
`
`- Assignn-IenI1 or 9
`
`
`
`Conveyance:
`RL-eI'Frame:
`Dale Recorded: Dc’. 2: 1991
`
`" lGllS THE -ENTIRE IEITERESY -‘l'lD T-{E C-CCU.‘-ILL
`
`Supporflng Documents: {lo Slsppornra-} Dcurmenls f~‘-'a:la:!-E
`Assignor
`
`Name:
`
`‘ll Er’ PIJETIQ RI-’."S l!lCZ
`
`Legal Emily ‘lype: CC HPCDHATKGH
`
`Asnlgnee
`
`Name:
`
`‘E"'?lTE3\ ¥lE—'«LTH l"RC-L‘»UCTE H22
`
`LegaIEn1:w‘ry9e: CCRPCR-‘-190:‘:
`
`AUIHBSSE
`
`
`
`Correspondent
`Correspondonl llama: SYHTEX iU 53.-'\.Il|'|=I
`
`'.-‘EHUE
`Conespondenlnduressz 33-0| H|:.L‘.‘lE*.-‘.
`-'- 3 EON 10850
`Fé‘.C >LlQ C.»‘-QJSCIE
`Dornesuc Representative - Not found
`
`v As5ignn1en12 of 9
`Conveyance:
`Raehframe:
`
`‘VGIJS THE EHTIRI: INTEREST HID ‘H-{E L'3=L‘C-D’.‘.lLL
`
`1{'T~E
`
`Pages: 2
`
`
`
`Date Recorded:
`
`Supponjn Ducuments:
`nsslgnur
`
`
`:‘l-5 '3-;:::c*r.tr:a Cit‘-:1_=.‘tet‘-l.= -‘<-zilazl-':
`
`Name: ?‘f:It‘E>- HE-aLTHFR-::f.t1-$.13 INC
`
`Execution Date: Jan 26 1213.:
`
`Legal Entity Type: CCRPCR%TlOtl
`
`State or Country Where GEL='.-'.-ARE
`Organized:
`
`Assignee
`
`Name: FP.CCTEF4—E"1'lJTEihE4LTH ,»=RC.‘EII_.=CT'3 l:C$.§F-'fl'I
`
`State or Country Where Cs-LEFDRIJIA
`Orunntzed:
`
`Legal Entity Typo: LEHER-'-L F'«‘~RTHE.==::3HtP
`
`Address:
`
`‘QT? BET F:O-'-E:
`to
`
`'-'-'1LT..:
`.' CCIl'.‘ECT|CUT
`
`Correspondent
`Corresoondenttlnnm: HARCLD LtlL3TElrtv»=2—t-'-D
`
`Correspondent Address: 3~‘.D1HlLL‘.:E“.‘
`UE
`
`-‘ma C'~LtFL‘.Rrll:,=J-£30:
`P-'-L
`Domestic Representative - Not Found
`v Assignment 3 of 9
`
`.-‘~SS|GN‘3 THE EHTlRE HJTEREST -‘-IJD THE G'3CD‘i‘t|LL
`Conveyance:
`Reel-Rania:
`
`Date Recorded: Fe; at
`1:19-1
`Supporting Documents:
`rlo Stlpmltir-i] D0¢ti~"'t:‘I‘.ls 4‘w3I|a2|-F
`Assiqnpr
`
`'§~:rti'E'x HE-'-LTH »'-FTCCUCTS
`name;
`Legal Entity Type: SCRPCR-‘-‘TICII
`
`
`
`Assignea
`
`llama:
`
`5
`
`SCTEI?-*3-‘t‘llt[r'. HE-.'.‘fH PRC E!|.‘Cl£3 CQr.tF.-Jii
`
`Pages:
`
`2
`
`Execution Date: Jan :6 193-‘
`State or Country Where F,EL‘«.‘.n‘¢Fx'lE-
`Orqaintedz
`
`Legal Entity Type: GEHER-'-L F‘-'-PIHERSHIP
`
`Adilre.-.5:
`
`1:3 -.‘.ES"t‘PORT ROAD‘.-‘.-il_TQIt.
`
`.T
`
`State or Countiy Where -'34LFF-3F'(ll“-
`Organized:
`
`Correspondent
`Correspondentltame: E-1'=RCLCH.'t!L'.5TElH
`"‘
`Correspomlertlilddress:
`D-
`
`J-UI HILLJE‘.-'.' "..-'£HlJE
`Fr-t.O.ALTO C4 ‘J-I30-1
`Domestic Represeniatnm - Not Found
`- Assignment 4 013
`
`-‘-S$tGl’.‘S THE ENTIRE INTEREST :.HE‘- THE GGCD-.‘.-iL.L
`
`conveyance:
`Reelitramci:
`
`Date Recorded:
`Supporting Documents: Ho Su'.‘:‘Cs"M--3 D?C|.ii"-'1Ei":T3 -'-.aita:l~3
`Asslunor
`
`Pages: 2
`
`Name:
`
`‘_“.’:‘lTEIY HE-'-LTH PRODUCTS III-Z‘
`
`Exactitmn Dale:
`
`Jam 225 193-!
`
`Legal Entity Type: CCRFOR‘-JIOI:
`
`State or Country where t.‘.-Eta-. .-LEE
`Organized:
`
`Asslgnee
`
`llama:
`
`"R'CCTF}?-‘F.'rTllE.‘. l-,E'—'.L TH FRCFH JETS C'.'.‘.l:lF»'~.'l‘i'
`
`Letlal EFIIIIY Twe: SE1-IEFHL P¢rtTIlERSHJF-
`
`Address:
`
`it‘! ;‘¢E‘3TP-CRT ROAD-
`:‘.iLTC>H Cftl-'.ECTlClJT
`
`State or Country where C-‘LIFGRI-1::
`Organized:
`
`Correspondent
`Correspondentllamei H=-RI;t.DI.tILf3TEttt
`Cnrrespondent Address:
`
`
`
`Dumaatlc Flapresantatrve - not Found
`'4' Assignment 5 Of 9
`
`I-:.‘~SiGt.'S {HE EuTtRE:i‘lTEREST
`Conveyance:
`Reelfrante: —' 4'-:3‘-E3
`Date Recorded:
`-“-Lt;
`1-‘. 199:3
`Supportmg Documents:
`'
`srpcrtin-; Deuinwents ‘-—a|i.‘l:|~.‘
`Assignor
`
`tlurne:
`
`T-CTL'}'?—'.‘~lllTElt li‘E-5.l.TH7|?L'.'[TiUL'.T.Z
`-
`.1 JHP-4'l'I'
`
`Pages: 2
`
`Execution Date:
`
`Jr,iI 22 117$--3
`
`Legal Entity Type: GEIIERAL F’é.RTl-EERSHIP L.‘-'-lEiER LAWS CF
`C~‘1..iz’-ifilillé.
`
`State nr Country Where no Flat: ‘.‘.‘|li!E Cl-{23|lIl&L.' Fuun-J
`Oraanlzcd:
`
`
`
`nsslgnee
`
`HPITHEI
`
`Leqa1Enury Type:
`
`1.1‘-iii"
`’~“"|lL-HE
`CC=RP=}R»'-TJOH
`
`AUU {E552
`
`
`M01 H|‘_L‘.TE'.'n', LEIIUE
`F‘-LC -’LTC C4J.|F3F?lJ\1a 913174
`
`state on country when:
`Organized:
`
`II-EL-‘«'.".'£f-‘IE
`
`
`
`HELLER, E‘:HI?I.|»‘-N ‘.‘.'HHE-L 32 H‘
`RCEERT E H5‘
`UlJ1aEP.E“'Y - EHJE
`
`.'3-J'l~1E5QCl
`.3 ALTO. C
`
`
`
`
`
`Correspondem
`Curresgmnrlenl Name:
`Canespnndent Address:
`
`Domestic Reprasenlalwe - Not Found
`- Assignment 5 DI‘ 5
`
`RECORD T’; ADD #1 -EC:lT|CH«‘-L P-GE TC 7:-{E “EEC ZR? '3? =11
`‘:31
`
`‘U0 K:«n5':
`
`1..
`
`'
`
`
`
`Execution Gene:
`
`Jun 2? 1996
`
`Slate or Country Where
`C-Iga1'1I1efl;
`
`=3b‘LLFL".
`
` sum: or Country Vihere
`Organized:
`
`
`
`Pages:
`
`.‘
`
`Execu11unDa!e: Dec 3? 19-"-'
`state or Country Where CEL»“.‘.
`
`Omannze-:1:
`
`State or Country Where H: Pia’
`Organlzen:
`
` 3r;3m:.=:F1un-:
`
`Panes:
`
`-'
`
`Execution Dale: Jan. 10 2
`Slate or Countrywhele DEL=-
`--RE
`Organixed:
`
`State or Country Where l3EL.¢‘.‘.'iHE
`
`Conveyance:
`
`RBBPFIGHIBI
`Dale Recorded:
`Supporting Documents:
`Asstgnur
`
`NEIITSBE
`
`1egaIEnhIy Type:
`
`=‘l-: Guucoltnng Dcsumer-ls A-.3:
`
`
`
`‘u
`‘ITFR-‘.'%‘n'HTF ‘( HF4-.l TH F-'FcCOL ‘CTR
`
`L'».,!'.IP-‘-III‘
`SE! JEFI-'-L P-‘-RTNERBHIP
`
`Asstgnee
`
`Name:
`Legal Eflllff Type:
`
`JTE- 4E-‘-LTH F‘F<OCUCTE, ‘if-EC
`
`CC.-’-!PCF'.—AT\0§:
`
`AGUTQSSI
`
`
`
`Correspondent
`Corresvont!entrlan1e:
`Carrcspontlenl Address:
`
`HELLER EHRM—‘.‘l LUHTE 5 MC-“ULlFFE
`WCBERT E H
`P.
`‘E U|'£l‘.E
`1«.‘eE1'l'n.!E
`
`
`F‘--0 ~‘-LTD C-'-.~J43L7‘|-1‘.1C|‘fJ
`Domestic Representative — Ilol Found
`
`v Assignment 7 of SI
`
`Conveyance:
`Reel-Frame;
`Dale Recorded:
`Suppomuu Documents‘.
`RBSIQIIOF
`
`-‘-SEIGHS THE EHTLRE LHTEREST
`u.
`an 0:
`5‘z,_.97
`
`:Ic '5u;.:£UI!:Ii'J DU-\‘u.-we:-.1‘; -‘..'a:Ia:i»3
`
`!13fl'|e:
`
`Legal Enmy Type:
`
`t'.""lTEI\ HELLTH PRZDUCTS !n';".)
`CCRPC-R-'-.TI'.3-*1
`
`Ass!-gnee
`
`"HIRE:
`
`Legal Enmy Type:
`
`AUUTESSI
`
`Correspoadani
`Correspondent Name:
`COFIQSDOIIHEM Address:
`
`
`‘
`I334 MILES I‘-‘JEHUE
`ELKH-'-RT L'lDJ=.H4...
`
`'
`
`E-‘-HER F\‘OCH"
`!:|Fl‘.-‘I'M -\ Sit-IVER
`158-: MILES 4'.EHL|E
`
`ELKHARI, EH :4.
`-1
`
` 11E'|
`
`"I"-'<'.‘GE CT I.--'-PE
` [r,.“_‘-
`
`fiomesuc Representative - Not Found
`v Assignmenl B c1‘9
`C onveyanze:
`Root Frame:
`DEN.‘ RQCOTUGUI
`.
`
`Suppomnq uocurnenzsz .,
`Asmpnor
`E-I'Efi-.‘-'63:!-if LL.-.
`‘..I5!|TED Ll-'-BLLITY C1I=I.!P:Il‘r
`
`“EH18:
`Legal Eniuly Type:
`
`Assignee
`
`Name:
`Legal Enury Type:
`
`EHER CCHIS _'I.‘E:! C-‘RE LLC
`Li':l|H:U :..V‘:E':'..5T‘I' :L'J!:||’ *-l'l‘{
`
`
`
`,u
`
`ulgumruu;
`
`AEEHDSSI
`
`'
` F ;.'ER5E'r' L'|7'.'-'32 ‘:fl‘|I.‘
`
`Correspannam
`JEFFRE‘r M GVTCHEL
`Corraspondenlrlama:
`Correspom1ar:1Address: 1”‘ !':‘i\‘E‘Q R0-'-II:
`
`Domestic Rapaasentative A Not§ound
`
`v Assignments of 5
`
`LIERC-FR EFFECTIHF DQ192006
`Conveyance:
`
` Reel Frame: ..
`Jan 10 200?
`Dale Recorded:
`Supponlng Documents:
`Assaqnor
`
`.3:-;1r;n*nont‘lrn—?.-1”:
`
`
`
`SAVER C-3H€'_5F‘|E7-T Cr‘-RE LLC
`5.‘?-IITED l_\»‘-E1LJT'I‘C. ”.‘F.!PiI-W
`
`llama:
`
`Legal Enuty Type:
`
`Execullun Date: 5-3:: 19.3
`State or Country Where E‘EL-'~‘.'."LF-IE
`Organized:
`
`
`
`=C=E-r\
`
`
`Slate orcounlnv Where lJE:L‘-
`Olganuzauz
`
`Name: E:-‘I'H-' HE1.*‘~LlH.
`Lit!I|'Eb Lb‘-E‘LIT‘u' C
`
`
`
`Leqa|En1m' Type:
`
`Assignees
`
`AUUFQSSI
`
`'13-} E-“1'E>'\’ R-3‘ .-
`
`~'-"\TY3Ei_IR‘.'_‘.H FF-IJ?l5:‘vL.
`
`Correspondent
`COHESIJOHGQHI Name:
`CDITESDKJHGEM Andreas:
`
`JEFFEE‘: M GETCHEL
`1{JL‘- E.-‘£1 ER RC-‘-D
`F'iTl"3ELJF-‘. H. 9%
`Dornesnr. Representaiive — not Found
`
`v Proceedings - Click to Load
`[1cm‘l1io3d inzicbe Read-3r
`
`If you are the anpiucant or the applicants attorney and ha we QUESEIOFIS about (ms file, piease contact the Tr3d&m_=.r'»: L-.ssnst3r.c-3 Center
`
`
`
`
`
`- En'\'2l';‘t'5:E'5-3-’:tL“'I}‘.' A-art:
`
`' 1- e’-1'." 2'
` *1 H.'oLY§Z3bOh and Fczsezd
`r'C'V‘»"\§-53' m1‘-e::r ard
`
` -1lx}'I {'-::1»‘J1] 1:‘.
`»- Bu-Jce.’ ?uPe1fr.':!n.:ncc
`
`-v “re-_-u.1'|:c",r1“:,v!r.aT.¢, x-'.;:
`(=c..;
`- Scaarlnscnt a.‘ Commerce
`H-<_\;E.5.R An Rep-;-rl
`~ Qe;*Ja::rs.c::.'
`- ‘.TTCP!Fa|ces ;t:\'
`
`- 5:mte;u 79--pd-2,; -C-:;.:v’.::u‘
`
`F‘zaC-
`:To.=g
`lnfaar:-amen Qua‘-t‘r‘ GL3-«:—cl,n-2:
`-7
`
` "1!’J{2I'
`
`
`
`United States Patent and Trademark Office
`.-‘tn .-\g,cncy nfilic l')t-p.iriiiiuiii nI‘tIn1miiui'cc
`
`Trademark Status and Document Retrieval
`
`About usnro imam T_r:§-err-a H-1
`198:1-cnvoliqi Prndinzutserviszs Careers
`USPIO : Irarlemarlc :~ ‘ISDR > Trademark Search
`H
`‘ Tl'«"idEI1iE*r!’3( Status 8; [)ociimenl' ltetrievoi (TSDR) 0
`SEARCH
`fJULTl—SEARCi!
`
`[mentors
`
`Ila-alumina eaudnesslnlcns
`
`FAQ;
`
`Fm-Kids
`
`0
`
`US i'eegr.a:ra:i:n nu
`
`{ii 3237750
`
`I‘r0CLI!'.'lE?lTS
`
`Generated on:
`Maik:
`
`0
`This cage was ;',-:—iI».=i.ii-3-3 3; TBEIF? Cl‘! 2015-0-'-2917) J
`-'-Lt‘-E
`
`US Serial Number:
`
`us Registration Number:
`Med as TEAS Plus:
`Register:
`Mart. Tyne:
`Stains:
`Status Date:
`Publication Date:
`v Mark Information
`I'.Iork Liicrai Eieinenist
`Standard Character Claim:
`Mark Drawini] Typn:
`
`.
`
`‘
`
`flpniicalioiiiiiiiigfiate: Fe: 13,2007
`RE5]l‘.3HdliDfl Date: Set 0: 230?
`2
`Ctirremly TEAS Plus:
`‘i‘~.
`
`E6 -3-’:
`
`stla-'a=‘ic:n n.)
`
`E SE?
`
`n scca-pi-J-d 30*: 3'.‘-I10-vi-liflsjrlfl
`
`A Se-:1inn:~ E and W: c;im:'.in
`a‘-tr). 13 231':
`Jun 19 SOLE?
`
`ALE‘-SE
`‘:‘;v.
`|'n-: mark consists oi sun-1.3:‘: r;iarac:r,r5 .-wzwaiil clam 1-: an, panic-.iiar 39-" Hr”: 3:25 or com
`4 - EST:-lJF;=RD Cli-’¢?<v‘~CFER ! l~‘RI-x
`
`- Related Properties information
`1i.".‘0-$2
`Ciiumed Ownership ol US
`Registrations:
`v Goods and Services
`
`Poi‘.
`
`Jntameiuonalclassiesli
`Class Status:
`Basis:
`Fxistuse:
`
`(DICE
`2’-narniaceutical -lntiluazire-U_In rreearsticns Fr-2-3-2ir:\IiGrI">1~:\FI!€.1TIrW~;
`'
`..
`\i.SCl.iss(esl; U05 D18 11
`ACTIVE
`123:
`Jul
`
`'
`
`2900
`
`U5eil‘ICOt11lI'\‘3l‘CE‘. Jil 3 r.
`
`v Basis lnforniation (Case Levei)
`Filed Use:
`F1lo(i[¥U:
`filed -1-1D:
`Fifed «HE:
`filed EGA:
`Filed No BGSISZ
`
`.
`
`-
`2'13
`formation
`E-a.9i Heallhcare LLC
`1E-C- E‘-:i;.~3-’ Rom
`I5-itisciirgh F‘EI1tJS‘it.'.-AH|- 1
`UHITED STATES
`=_if.liTED L!‘-EELITY C-’_‘;I.%F‘-"-i'i‘»'
`
`- Current Dwnertsi In
`Owner Name:
`Owner Address:
`
`Legal Entity Type:
`
`v Attorneylcorrespondence Information
`Attorney oi‘ Record
`Attorney Name’.
`Attorney ilnrriiiry Emai!
`Address:
`
`Jc;:ii».=.,f.i Gihfn:-I
`
`Correspondent
`Correspoiident
`!iame‘.ndr.1ress‘.
`
`Je'1re- H P3115415!
`Ea
`Icoinaratizrn
`1i'if:F:.‘.\‘£fi on
`
`Ameiiitcii Use: No
`Amended ITU:
`rm
`Amended -MD: Hr.-
`Amended Adi:
`[K
`
`Currenity Use:
`CurientIy1TU:
`Currentiy-HD:
`Cisrranw44E:
`Currently 6-SA:
`Curreiiily zlo Basis:
`
`.
`
`520:}
`
`State or Country Where CE
`Organized:
`
`Dcickeittunioon 333968
`Attorney Emmi Aiiinnrized;
`‘res
`
`
`
`
`Tr:_--:"1arvs
`,'-‘vlTT:':'ELlR-.3H PEllHSYL';LNln 1€?L15—§.7D?
`UNITED t.‘-YATES
`.ii'¢?‘.-‘T-'-3-ii)
`
`
`:;..i«crTl‘.)
`"|'_i!‘»U§
`
`.x.a'.'=.-r.v.'mn
`
`Phone:
`
`Correspondent e-ma
`
`Fax: 412775144 32
`Correspondent E-mdll
`‘r-:-5
`Aulnorared:
`
`Dornauuc Representative . [501 Found
`v Prosecution History
`Dare
`flG.r1ZEC-13
`
`NOV. 13. 2013
`
`‘=3
`0:1. 25 2
`rim 112C-13
`
`LIL! T5 2:113
`Sap l‘:-', 266?
`Jun. 19 2\'JL'I':'
`LIE‘;
`'3'? 2007'
`M3» 1-: 2037'
`Asr, E3 203?
`-‘-{tr
`1-’: EH37
`Liar 2? 236?
`Mar 1‘? EJB7
`Fe:
`154 20:17
`
`-JJCC QF SEC 3 .‘.1E—E—
`
`Descripuon
`NOTICE I31’ ‘CC:
`
`ll-'-JLED
`REGEF,‘-TERED - SEC 3 L6-YR] QCCEPIED in SEC 1:"
`=‘.CK
`RE«3=‘_‘—IER'EE: ~ SEC EV3-(R15 SEC 15 ?LED
`C-'~SE.-‘SGIGNED TO POST REGISTFRTICII
`P-‘-R.v¢EG=‘L
`
`:7E~‘-To
`CTICH B 5. if RECEIVED
`REGi'5TEF-7:EDAFRl\CE~'7#L REGISTER
`FUELISHED FCR C‘-FPCf:lTiO!-J
`HOTECE CF PiJElJC4T|7.‘.H
`7E.-L3 RESPONSE .,‘ CFFECE RCTICW F\E'CEi\'ED
`‘.' C'3l.lF'LETED
`L1.’.'.'GFF1C.‘E PUBLIC-'~T|C.’l REE‘;
`-'-S811‘-l.‘EDTf.‘L:E
`=FFRC‘~'ECi FOR FL? FRI!-JC§F’iL FEGIETER
`“-SEE.'$l.‘FD 13 E \-\!.ilHFR
`HE'.‘.'_=rPFLIC-‘xTlC)!l ENTERED iii mm
`
`Proceeding Number
`
`r2TTE_‘3
`
`E723
`-37723
`
`T9824
`?(
`3-1
`
`
`
`- rdalntenance Filings or Fast Registration Information
`
`nrfldavit oicnnlmued Use:
`*1 —:n 8 - tats-mar:
`
`1.‘-A -‘i::2r.l-2:‘.
`‘E.€:.?1|-Iii
`Mirdavn nflncontastability:
`v T” Staff and Location Information
`TI4 Start Inlnmlatzon —None
`File Lucalion
`Currenl LDCBHDIII THEE L
`
`-'-.‘.‘ C‘-FFlCE ‘I-7
`
`- Assignment Abstract Of ‘File Information - None recorded
`- Proceedings - Click to Load
`Dov. nlafld .‘.C.‘<‘.l‘=~‘» i§'-ind-:r
`
`[late in Lucallon:
`
`I-‘Dr
`
`‘.3 26:13
`
`[fvou are the applicant or the applicants attorney‘ and have questions about this file, please contact the Trad~:mar‘r. -7«Sfil3h‘l.':C9 C- nt~:r
`
`
`
`- :«::,ess$.‘a:‘r
`_, Pm3:,,. Faicy.
`. 757.5 :IrU;,_.
`o Etzxzrlti
`’= Em:-:(;e':c:-.-::,"-£e:Llrtt;.'Alerls
`
`v Federal A:u‘;.:-asir-merits:
`l-‘sf-mi. (7-AER} Ac:
`
`r rl::fr;:.to:: 3*-d Friar "
`
`
`
`J Eudc I S‘,
`-
`2
`acrfcrmanx
`
`- ficedrxn cf infarmatm An
`[1-DEA)
`- :r:o.1u':r£.'l: of C:-rrmer-:5
`-
`r
`M
`._ .cc,.
`“ 5I—,._-0.,“-_¥¢_s
`.‘
`
`‘W:
`
`' Stramql Tar;-nil-ii; L}-gyirrcd
`Put.-,‘ (1-;'|'(J'»")
`
`
`>5 In rrnauo-'1 Qua‘-w |3u'ceinL“3
`» uarvro .-
`I train: of